Stocks and Finance

Merck

Merck 2/7/2012

14:25 : Summary Box: Merck reports anti-clot drug data - STRIKE TWO: A second study shows Merck's experimental anti-clotting drug vorapaxar increased risk of dangerous internal bleeding, including inside the skull. The study, called TRA-2P, did show vorapaxar lowered risk of heart attack, stroke and death....
Source : usnews-com
13:20 : Merck anti-clot compound again shows bleeding risk - TRENTON, N.J. (AP) -- An experimental anti-clotting drug that Merck & Co. is developing was found to increase risk of dangerous internal bleeding in a second study, meaning it's unlikely to achieve the blockbuster status ...
Source : usnews-com

Merck 2/2/2012

16:55 : Summary Box: Merck swings to profit in 4th quarter - BACK IN BLACK: Higher sales of most key drugs and lower charges push Merck & Co. back to a fourth-quarter profit. Adjusted income of $2.98 billion, or 97 cents a share, beat expectations, but sales were a tad short....
Source : usnews-com
09:44 : Merck sales fall short, issues flat 2012 forecast - Merck & Co on Thursday reported weaker-than-expected quarterly sales and predicted relatively flat 2012 results as the No. 2 drugmaker girds for cheaper generic forms of its biggest product, asthma drug Singulair.
Source : ibtimes-com
09:25 : Merck profit beats as research trimmed - (Reuters) - Merck & Co on Thursday reported better-than-expected fourth-quarter earnings, helped by a decrease in research spending, and predicted relatively flat 2012 results as the No. 2 U.S. drugmaker girds for cheaper generic forms of ...
Source : reuters-com
09:10 : Merck Close to 52-Week High After Earnings (MRK) - The following commentary comes from an independent investor or market observer as part of TheStreet's guest contributor program, which is separate from the company's news coverage.#xD; NEW YORK ( Bullion Bulls Canada ) -- In Part 1, I laid ...
Source : 247wallst-com
08:39 : Merck earns $1.5 billion in fourth quarter - LONDON (MarketWatch) -- Merck & Co. Inc. on Thursday said it swung to fourth-quarter profit of $1.5 billion, or 49 cents a share, against a $531 million loss in the year-ago period. Revenue increased 2% to $12.3 billion from $12.1 billion ...
Source : marketwatch-com
08:04 : Merck & Co. swings to Q4 profit on lower charges - WHITEHOUSE STATION, N.J. (AP) -- Drugmaker Merck & Co. said Thursday that it swung to a fourth-quarter profit because of lower acquisition and restructuring charges and slightly higher sales....
Source : usnews-com

Merck 1/31/2012

15:19 : Merck & Co. Earnings Preview: Q4 Benefits from Diabetes Drugs, Cost Reducti - Merck & Co., the second-largest U.S. drugmaker, is projected to report stronger fourth-quarter profit on double-digit growth of key products, an increasing emerging markets presence and further cost reductions.
Source : ibtimes-com

Merck 1/30/2012

03:25 : Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment - Merck Serono Receives the 2011 Europe Frost & Sullivan Award for Competitive Strategy Leadership in Recognition of the Success of Its Comprehensive Portfolio of Hormone-Based Therapeutic Products and Strategic Expansion Across European and ...
Source : marketwire-com

Merck 1/19/2012

19:10 : Summary Box: Merck settling Canadian Vioxx cases - VIOXX DEAL: Merck and lawyers for Canadian Vioxx users have struck a deal, awaiting approval by courts in provinces there, to end lawsuits filed by hundreds of people claiming harm from the drugmaker's recalled painkiller Vioxx....
Source : usnews-com
17:47 : Merck to settle Canada Vioxx suits for up to $37M - WHITEHOUSE STATION, N.J. (AP) -- Drugmaker Merck & Co. has reached a deal to settle all lawsuits in Canada over its recalled painkiller Vioxx, for up to about $37 million....
Source : usnews-com

Merck 1/5/2012

13:19 : Merck CEO: This year will be better than 2011 - TRENTON, N.J. (AP) -- Merck & Co.'s CEO said Thursday that setbacks in drug development and other problems made his just-ended first year a tough debut....
Source : usnews-com

Merck 12/23/2011

15:35 : Strong Does Of Momentum In Merck Stock, Next Stop $42 - Merck is currently the world’s second-largest pharmaceutical company. The company is a global health care provider that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, Animal Health|animal ...
Source : forbes-com

Merck 12/20/2011

14:06 : Merck to pay Mass. $24M in Medicaid fraud settlement - Pharma giant Merck & Co. Inc. (NYSE: MRK) will pay $24 million to the state of Massachusetts, according to a news release from the state Attorney General’s Office. The payment is part of a $47 million Medicaid fraud settlement involving 13 ...
Source : bizjournals-com

Merck 12/12/2011

12:13 : ABLYNX AND MERCK SERONO SELECT A NOVEL NANOBODY CANDIDATE, ALX-0761, FOR ... - GHENT, BELGIUM--(Marketwire - Dec 12, 2011) - Ablynx [Euronext Brussels: ABLX] and partner Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that they have advanced the Nanobody candidate, ...
Source : marketwire-com

Merck 11/28/2011

16:26 : Facebook apologizes for Merck homepage mix-up - Facebook Inc said on Monday that it made a mistake in letting Merck & Co take over a page on the social networking website from its German rival Merck KGaA.

Merck 11/23/2011

02:32 : Merck to pay $950 million to settle U.S. Vioxx charge - (Reuters) - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday.
Source : reuters-com

Merck 11/22/2011

20:14 : Merck settles with states, including Oregon - Pharmaceutical company Merck will pay the state of Oregon $1.65 million as part of a $950 million agreement with 43 states. The national agreement with Merck Sharp & Dohme Corp. resolves civil and criminal allegations that the ...
Source : bizjournals-com
17:15 : Merck to pay $950 million to settle Vioxx charges - SAN FRANCISCO (MarketWatch) -- Merck & Co. Inc. has agreed to pay $950 million to settle criminal and civil charges related to the misbranding of painkiller Vioxx, the Justice Department said Tuesday. Under the agreement, Merck ...
Source : marketwatch-com
16:45 : Merck to pay nearly $1 billion over Vioxx - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller drug Vioxx for an unapproved use, the DOJ said on Tuesday.
Source : msnbc-msn-com
16:22 : Merck will pay $950M to settle Vioxx investigation - NEW YORK (AP) -- The Department of Justice said Tuesday that drugmaker Merck will pay $950 million to resolve investigations into its marketing of the painkiller Vioxx....
Source : usnews-com
15:54 : Merck to pay nearly $1 billion to settle U.S. charges - (Reuters) - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller drug Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday.
Source : reuters-com
15:51 : Merck to Pay $950 Million in Vioxx Settlement - Merck will pay $950 million to settle criminal and civil charges that it illegally promoted the painkiller Vioxx, the Justice Department announced.
Source : wsj-com

Merck 11/18/2011

16:01 : ADR's of German chemical and pharmaceutical maker Merck KGaA ([[MKGAY.PK]] - ADR's of German chemical and pharmaceutical maker Merck KGaA (MKGAY.PK +0.7%) get a lift after receiving a positive opinion from a committee of the European Medicines Agency for its application to extend the indication of Rebif, its leading ...
Source : seekingalpha-com

Merck 11/10/2011

13:09 : Merck: Promising drugs in late-stage testing - WHITEHOUSE STATION, N.J. (AP) -- Merck & Co. said Thursday it has revamped its research operations to make them more productive and has started a new four-pronged business strategy to increase revenue and profit....
Source : usnews-com
09:22 : Merck hikes dividend by 10.5% - NEW YORK (MarketWatch) -- Merck & Co. Inc. said Thursday it will increase it quarterly dividend by 10.5% to 42 cents a share from 38 cents a share. The pharmaceutical company said shareholders of record as of Dec. 15 will be paid the dividend ...
Source : marketwatch-com

Merck 11/9/2011

01:55 : Ablynx and Merck Serono Expand Their Partnership Into Osteoarthritis - GHENT, BELGIUM--(Marketwire - Nov 9, 2011) - Ablynx [Euronext Brussels: ABLX] today announced that it has further expanded its relationship with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and entered ...
Source : marketwire-com

Merck 10/28/2011

11:07 : Merck Posts Strong Earnings on Gains from Asthma and Diabetes Drugs, HPV ... - Merck & Co. announced on Friday that its net income grew to $1.69 billion from $372 million in the prior-year quarter, as gains from the company's diabetes and asthma medication offset losses from their Remicade and Simponi treatments for ...
Source : ibtimes-com
07:17 : Merck quadruples 3Q profit, beats analysts' views - WHITEHOUSE STATION, N.J. (AP) -- Drugmaker Merck & Co. said Friday that its third-quarter profit soared from results a year ago that were weighed down by huge acquisition and legal charges....
Source : usnews-com
actualidad Merck -
Logo Merck

Merck by date


Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Biotechnology

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts